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Abstract
Background: Chlamydia trachomatis is a common human pathogen that mediates disease processes capable of inflicting
serious complications on reproduction. Aggressive inflammatory immune responses are thought to not only direct a
person’s level of immunity but also the potential for immunopathology. With human immunobiology being debated as a
cause of prevailing epidemiological trends, we examined some fundamental issues regarding susceptibility to multiple
chlamydial infections that could have implications for infection spread. We argue that, compared to less-frequent exposure,
frequent exposure to chlamydia may well produce unique immunobiological characteristics that likely to have important
clinical and epidemiological implications.
Methods and Results: As a novel tool for studying chlamydia, we applied principles of modeling within-host pathogen
dynamics to enable an understanding of some fundamental characteristics of an individual’s immunobiology during
multiple chlamydial infections. While the models were able to reproduce shorter-term infection kinetics of primary and
secondary infections previously observed in animal models, it was also observed that longer periods between initial and
second infection may increase an individual’s chlamydial load and lengthen their duration of infectiousness. The cessation
of short-term repeated exposure did not allow for the formation of long-lasting immunity. However, frequent re-exposure
non-intuitively linked the formation of protective immunity, persistent infection, and the potential for immunopathology.
Conclusions: Overall, these results provide interesting insights that should be verified with continued study. Nevertheless,
these results appear to raise challenges for current evidence of the development of long-lasting immunity against
chlamydia, and suggest the existence of a previously unidentified mechanism for the formation of persistent infection. The
obvious next goal is to investigate the qualitative impact of these results on the spread of chlamydia.
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Introduction
The genus Chlamydiae encompasses a unique class of obligate
intracellular bacteria that can cause disease in a wide range of
animals [1]. Similarly to all other commonly reported sexually
transmitted infections (STIs) (e.g., gonorrhea), Chlamydia trachomatis
(Ct) represents a unique and important public health concern, as
prevention efforts are hampered by cryptic infections and delayed
diagnosis [2,3]. This ability to thrive, despite improved under-
standing of the immunobiology, pathogenesis, and epidemiology
of this bacterium [3], has made it the world’s most common cause
of sexually transmitted disease [2].
Chlamydia bacteria have a biphasic developmental cycle that
consists of an extra- and intracellular form [1–2]. The extracellular
form, the elementary body (EB), is infectious and thought to be
metabolically static. During infection, the EB is internalized into
host epithelial cells via small vacuoles resembling endosomes, most
of which avoid fusion with host cell lysosomes [2]. The EB
differentiates within the entry vacuole into metabolically active
reticulate bodies (RB), which are non-infectious [2]. Infection is
propagated further when the RBs differentiate back into EBs,
which are released from the host cell by either exocytosis or lysis.
Inference by analogy with rodent models supports the existence
of an effective immune response against Chlamydia bacteria [1–10].
These models of genital tract infections demonstrate that a large
proportion of animals resolve primary infection and are tempo-
rarily resistant to reinfection [4–10]. When reinfection does occur,
secondary inflammation and disease is significantly shorter, and
bacterial load is greatly reduced.
One of the major immune mechanisms for controlling Chlamydia
infection occurs through depletion of cellular tryptophan (TRP) by
indoleamine-2,3-dioxygenase (IDO) – a TH1 process that is
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TH1 response will allow Chlamydia RBs to respond to immune
challenge by converting into a nonreplicating but revivable
persistent state [12]. In this persistent state, chlamydia bacteria
have been demonstrated to remain able to direct their own survival
andstillallowforantigen-presentation[11].Adirectconsequenceof
this prolonged infection is antibody- or TH2-mediated hypersensi-
tivity [12]. However, an over-stimulated TH1 response will lead to
delayed-type hypersensitivity, and an increased risk of IFN-g-
mediated tissue damage. Effective immune responses that success-
fullyclearchlamydiainfectionwill containa proportionalbalanceof
cell-mediated and humoral immune responses [12].
With the exception of one early vaccine trial [13], equally-
detailed insights into human immune responses have not extended
beyond observational studies. However, elimination of infection is
likely immune mediated [14]. Studies that have investigated the
natural history of infections in humans have reported that
resolution of chlamydia occurs within months, even years [15–
17]. Previous estimates of the basic reproductive number (R0), in
conjunction with epidemiological evidence from core groups,
suggests that frequent exposure to Ct infections confers some
degree of strain-specific protective immunity [18]. While these
observed patterns are consistent with what might be produced by
individual immune responses, it is interesting to note that they
have not been directly measured [19]. As a result, this leaves some
elementary questions unresolved. To our knowledge, little research
has examined susceptibility to multiple chlamydial infections,
explored the effect of exposure history on an individual’s immune
repertoire, or investigated any consequences for the spread of
sexually transmitted Ct infections [4].
A person’s history of exposure to STI-causing pathogens has
been considered central to shaping their repertoire of effector B
and T lymphocytes, as well as for driving STI persistence and
evolution [19–20]. However, most, if not all, modeling related to
bacterial STIs is concerned with the population dynamics of these
infections. Although insightful, they often will disregard, or abridge
any within-host dynamics. To better study the complexity of
chlamydial infections within an infected individual, evaluate
patient-centered interventions, and indentify future research
priorities will require novel analytic tools [19,21–22]. Our present
objective, through numerical and analytic study of two within-host
dynamic models, is to illuminate unique immunobiological
characteristics that may result from differences in exposure history
to chlamydia.
Methods
Our aim was to consider a highly parsimonious model and
explore its dynamics in the context of repeated chlamydia infection.
To do so, we constructed two simple mathematical models with
explicit expressions for chlamydia bacteria, host target cells of the
genital tract, and chlamydia-specific immune responses. The first,
we termed a ‘basic’ model, and the second, an ‘extended’ model.
These two structures represented a combination of dynamical
hypotheses about chlamydia immunology. Throughout this study,
they allowed us to iteratively investigate, and build confidence in,
the role of both CD4+ T cell, and anti-chlamydia antibody
responses under different exposure histories. Specific details of each
model are discussed below, and schematically in Figure 1.
A Basic Model of Within-Host Chlamydia Replication with
CD4+ T cells
We elaborated a simple within-host model developed first by
Nowak and Bangham [21]. Briefly, this model contains three
variables that represent the population of uninfected cells, (X),
infected cells, (Y), and cells of an intra-cellular pathogen (which, for
the majority, have been viral particles), (V). Uninfected cells are
produced at constant rate, l, from a pool of precursor cells and die
Figure 1. Stock and flow diagram illustrating the assumptions about chlamydial dynamics in the models. Displayed is a schematic
representation of equations 1–5 in the main text. Uninfected ECs (X) are produced at a constant rate, l, and die at a rate dX. Infected cells (Y) are
produced at a rate bXE by contact with free EBs (E), and die at a rate aY. CD4+ T cells (Z) proliferate and differentiate at a rate cY and die at a rate sZ.
Infected cells recover from infection at a rate cZY. Antibody (U) is produced at a rate jZ. Antibodies decay at a rate gU, neutralize EBs at a rate kUE,
and are consumed in an EB-antibody complex at a rate w kUE. Basic and extended models are labeled by curved braces. Dashed arrows between state
variables indicate interactions between them.
doi:10.1371/journal.pone.0006886.g001
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free virus at a rate bXV and die at a rate aY. Free virus is produced
from infected cells at a rate kY and decline at a rate uV. Each of
these quantities can denote the total abundance in a host, or the
abundance in a given volume of blood or mass of tissue [23].
Because chlamydia bacteria are intracellular pathogens, the
above model of viral dynamics was easily extended to model
chlamydial dynamics. Our basic model included uninfected
endothelial cells (ECs) of the genital tract (X), infected ECs (Y),
free, infectious, and metabolically inactive EBs (E), TH1 CD4+
cells (Z). Uninfected ECs were produced at a constant rate, l, and
died at a rate dX. We used mass-action kinetics to model the
interactions of uninfected cells with infectious EBs; infected cells
were produced at a rate bXE, and died at a rate aY. We further
assumed that activated chlamydia-specific CD4+ T cells prolifer-
ate and differentiate at a rate cY. In reality, the activation and
proliferation of CD4+ T cells is induced by antigen-presenting
cells; however here, we followed Nowak and May [23] in assuming
that activation and proliferation is roughly proportional to the
number of infected cells. Activated CD4+ cells died at a rate sZ.
The main effector mechanism of CD4+ T cells assumed in this
model was IFN-g-mediated TRP starvation of chlamydial RBs.
Here, the concentration of IFN-g and cytosolic TRP were modeled
implicitly, and the concentration of each was assumed to be
directly- and inversely proportional to the number of CD4+ cells,
respectively. Because low levels of TRP have been demonstrated
to have minimal effect on the viability of host cells [24], infected
cells were therefore assumed to recover from infection at a rate
cZY. These assumptions produced the set of ordinary differential
equations:
_ X X~lzcZY{dX{bXE ð1Þ
_ Y Y~bXE{aY{cZY ð2Þ
_ Z Z~cYZ{sZ ð3Þ
_ E E~eY{qE: ð4Þ
An Extended Model of Within-Host Chlamydia
Replication with CD4+ T cell and Antibody Responses
We extended the basic model to include chlamydia-specific
antibody (U) that inhibit infection of genital tract ECs at a rate w
kUE. For this model, we ignored the effect of antibody-mediated
cellular cytotoxicity because its significance during chlamydia
infection has yet to be determined [10,25–26]. We followed Yao et
al [27] in assuming the production of antibody, j, is proportional
to the number of CD4+ cells. Given that antigen-specific B and T
cells are activated and proliferate in local lymphoid aggregate
tissue in the genital tract by similar mechanisms [2,27–28] our
model assumed that they were roughly proportional to each other.
For chlamydia, this appears to be a reasonable assumption for two
reasons: the first because immune-mediated resolution requires a
proportional balance of both TH1 and TH2 responses [11–12];
and the second because previous data suggest that the protective
response of antibody is dependent upon CD4+ cells [10]. Previous
studies that have explored this issue in sufficient detail for
recurrent viral infections found negligible impacts on conclusions
[27]. From Yao et al. [27], the natural decay rate of the antibody
population was denoted by g, the efficacy of antibody-induced EB
neutralization is denoted by k, and the number of antibody
particles that are consumed in forming an EB-antibody complex is
denoted by w.
Because our main interest is in the dynamics of the immune
response under repeated infection, we included no explicit
representation of the formation of memory T or B cells in either
the basic or extended models. Instead, we model immune memory
by letting our populations of immune cells (i.e., CD4+ T cells or
antibody) die off slower than other cells following infection. There
were two reasons for this: the first was because the results of the
main study we were attempting to qualitatively reproduce did not
explicitly measure populations of memory T cells [5]. Instead, T
cell activity was reported an aggregated time series. This was later
identified as CD4 T cell activity. As a direct result of this, we
secondly thought it more appropriate to assume a heuristic
approach over a mechanistic description of immune memory,
since the end-result of immune memory (i.e., elevated levels of
certain immune cells for some time after stimulation) is universal.
These assumptions modified equation 4 of the basic model and
produced an additional equation for antibody kinetics to form the
extended model:
_ E E~eY{kUE{qE ð49Þ
_ U U~jZ{wkUE{gU: ð5Þ
Both models were solved numerically using the default Euler
integration method in the modeling software Vensim DSS for
Windows (version 5.5d).
Because these models are deterministic, CD4+ and antibody
state variables cannot drive Y(t)o rE(t) to zero. Therefore,
following Wodarz et al. [29–30] we defined a threshold value
below which chlamydia infection was considered extinct. Our
extinction threshold was arbitrarily chosen to be marginally larger
than the endemic equilibrium value of a model lacking a
threshold, such that a single infection would eventually be cleared.
We included an extinction threshold because we anticipated that
this would better match empirical observations of individual
infection and immune kinetics than a model without an extinction
threshold. Initial conditions for the models were X(0)=100,
Y(0)=0, Z(0)=1, E(0)=0.01, for both basic and extended models,
and U(0)=0.01, for the extended model.
Clearly, a complete mathematical description of the immune
system is neither feasible nor analytically tractable, due to the vast
complexity of the immune system. However, recent theoretical
work has demonstrated the merit of simple mathematical models
in reproduction and explanation of experimental results [29–33].
Our model structures were purposefully kept simple so to focus on
broad immunobiological insights. The philosophy behind starting
with a simple representation of a complex system designed to
address certain well-defined questions is similar to that motivating
the methods of experimental scientists [33]. Such simple models
can often lead to important insights of a general nature into the
factors or processes that shape epidemiological patterns [33].
Parameterizing and Calibrating the Models to
Experimental Data
Often, obtaining experimental estimates for many parameters in
a model can be difficult [23,27]. Where possible, however, the
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on previous research [2]. Where no experimental or observational
information could be readily obtained, the remaining parameters
of the two within-host models were either taken from similar
models [23,27], or were calibrated to qualitatively approximate
published experimental data from both mouse and guinea pig
models [3–5,7,8,10]. Specific parameter values are listed in
Table 1. To ensure comparability between model and previous
laboratory results (i.e., independence from particular units), all
experimental and model results are presented non-dimensionally.
Re-exposure Scenarios
Because exposure history to, and subsequent reinfection with,
chlamydia is of current epidemiological concern, we examined the
long-term within-host dynamics under four different re-exposure
scenarios. The first scenario was intentionally chosen because it
mimicked protocol from previous experimental studies using
guinea pig models. Here, a single re-exposure occurred approx-
imately between 70 and 80 days after the resolution of a primary
infection. The second investigated single re-exposure at regular
intervals at 100, 200, 300, or 600 days after primary infection. The
third scenario studied multiple re-exposures, every 30 days within
300 days of primary infection. The fourth was a combination of
scenarios one and three (i.e., frequent re-exposure, though not as
frequent as scenario three, within 300 days followed by a single re-
exposure at 900 days after initial infection). The second through
fourth re-exposure scenarios were chosen to be arbitrarily to aid in
our understanding of the systems of equations would behave over
longer time horizons. Re-exposure was modeled by an instanta-
neous inflow of EBs at each of the above-described times using a
multiple of the initial infectious dose (i.e., 106E(0)).
Results
Both Models Reproduce Experimentally-observed
Kinetics of Primary and Secondary Chlamydial Infections
Figure 2 illustrates that previously observed kinetics of infected
cells and CD4+ T cells (Figure 2A) can be approximated by the
basic model (Figure 2B). Although it may be argued that our
parameter values do not exactly reproduce experimental results,
we do not feel that our results stray qualitatively from what would
be expected in reality. The presence of qualitative, rather than
quantitative, similarity does not diminish the value of the insights
gained through careful analysis of mathematical models [30].
While not demonstrated here, a version of the extended model
that assumed antibody as the sole immune response was unable to
resolve primary infection. This further reaffirms that CD4+ T cells
have a decisive role in resolving infection.
Figure 3 illustrates the behavior of the basic and extended
models when exposure to a second chlamydia infection occurs. In
both basic (Figure 3A) and extended (Figure 3B) models, a second
infection is predicted to be of decreased magnitude. However,
there are some interesting differences between the magnitudes of
immune responses in each model: in Figure 3A, second infection at
75 days results in increased CD4+ cell activity compared to initial
infection. These are common kinetics of free EBs and CD4+ T cell
activity during a second infection in the absence of antibody [3]. In
Figure 3B, reinfection at 75 days demonstrates a delay in positive
growth of free EBs. While this is in contrast to the results of the
basic model, it is this delay that supports the role of antibody in
controlling reinfection [10].
Increasing the Time between Initial and Second Infection
increases Bacterial Load
In Figures 4 and 5 we examined a single re-exposure at
increasingly long intervals from initial infection (re-exposure
scenario 2). In the case of both models, similar dynamical
behavior is observed: as the time between initial and secondary
infection increases, the severity of that second infection also
appears to increase. In the basic model this is associated with an
increased magnitude of infected cells (Figure 4A). In the extended
model, this was illustrated by an increased duration of elevated
infected cells (Figures 5A).
Immune responses were also affected. For the basic model,
reinfection at later times from initial infection appears to produce
higher levels of CD4+ cells (Figure 4B). In the extended model,
however, negative feedbacks associated with both antibody and
Table 1. Parameters for the basic and extended models.
Parameter Description Value (day
-1) References
l
1 Rate uninfected cells restock. 1.54 25
b
1 Infection rate. 2.31 3-5,7-8,10
d Uninfected cell die-off. 0.01 3-5,7-8,10
a Infected cell die-off. 0.01 3-5,7-8,10
c
1 Rate infected cells are ‘‘cured’’ by CD4+ cells. 6.58 3-5,7-8,10
c
1 T cell responsiveness rate. 1.86 24
s T cell die-off. 0.02 3-5,7-8,10
e
1 EB
{ production rate from infected cells. 2.02 2
q Rate of EB decay. 2.00 3-5,7-8,10
j*
1 Ab
{ production rate. 0.12 4,9-10
g* Ab decay rate. 0.05 4,9-10
w*
1 Number of Ab consumed per disabled EB. 5.41610
-5 4,9-10
k* Rate EBs are disabled for each EB-Ab complex. 0.001 25
{EB = Elementary Body;
{Ab = Antibody.
Parameters included in the extended model are indicated by (*). Parameters with (1) have been scaled to be dimensionless with respect to state variables. Scaling was
based on an arbitrarily select reference category. State variable reference categories (yref, eref, zref,a n duref) were the peak values (or lowest, for xref) at initial infection.
doi:10.1371/journal.pone.0006886.t001
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seen for initial infection (Figure 5B and 5C).
Repeated Exposure Reinforces the Importance of
Antibodies and Suggests a Role in Preventing Persistent
Infections and Immunopathology
In addition to repeated single re-exposure, Figures 4 and 5 also
display frequent re-exposure, as might occur amongst commercial
sex workers or core members of a sexual network (re-exposure
scenario 3). Figure 6 contains the simulated outcomes for someone
who is experiencing higher initial frequency of exposure, though not
as high as scenario 3, followed by a long period of no exposure (re-
exposure scenario 4). For EBs and infected cells in the basic model
(Figure 4), frequent re-exposure every 30 days produced damped
oscillations that approach a low endemic equilibrium that persists in
the absence of further exposure. Given that CD4+ T cell responses
are positively correlated with production of IFN-g, the basic model
demonstrates that frequent re-exposure is likely to keep CD4+ cell
population elevated, and the production of IFN-g continual.
For baseline values of the extended model, where an individual’s
antibody response is proportional to CD4+ cells, this behavior was
not demonstrated (not shown).However, by lowering their antibody
response, frequent re-exposure produces similar elevated predator-
prey like immune responses and persistent infection that continued
in the absence of further exposure (Figure 5). Repeated exposure,
regardless of how frequently it occurs does not affect the behaviour
of the models. In fact, the model’s trajectories to both the endemic
equilibrium (basic model) and the limit cycle (extended model) are
conserved regardless of how frequently re-exposure occurs. An
analytic study of re-exposure corroborates the simulated results for
both basic and extended models (Supporting Information S1;
Figure S1). Taken together, this suggests that a proportional
antibody response may have an important role in preventing the
formation of persistent infection. Figure 6 demonstrates that
removing short-term frequent exposure to chlamydia allows partial
immunity (i.e., immunity that does not prevent infection, but will
reduce the duration and severity of second infection) to wane and
return to near baseline levels.
Figure 3. Secondary challenge experiments using the basic and
extended models. Re-exposure was modeled by an instantaneous
inflow of EBs at each of the above-described times using a multiple of
the initial infectious dose, 106E(0) for both the basic model (A), and the
extended model (B). In both panels, second infection is decreased in
severity because of some residual population of T cells (A) or both T
cells and antibody (B). The magnitude and time evolution of the system
of equations in both (A) and (B) have been rescaled (i.e., are presented
non-dimensionally) so to allow for a visual comparison. Because of
structural differences, the reference categories used for scaling were
different between basic and extended models. Black arrow indicates
time point of secondary exposure and CD4+ T cells and antibody are
plotted on the right axis.
doi:10.1371/journal.pone.0006886.g003
Figure 2. A comparison of experimental and simulated kinetics
of primary chlamydia infection and CD4+ T cell responses. (A)
Experimental data for infected cells and T cells at initial infection. Data
are modified from Igietseme and Rank [5]. Female guinea pigs were
infected with the same amount of Guinea Pig Inclusion Conjuntivitis
(GPIC) chlamydia bacteria. (B) Simulated behavior of infected cells (Y)
and CD4+ T cells (Z) for the basic model demonstrates similar
qualitative behaviour when calibrated to approximate part (A). While
both basic and extended models reproduced experimental behaviour,
only the results of the basic model are displayed. For comparison of
qualitative behaviour, both experimental and simulated data for
infected cells and T cells have been scaled and are displayed non-
dimensionally.
doi:10.1371/journal.pone.0006886.g002
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Human immunobiology and reinfection rates have been the
focus of recent debate in STI epidemiological literature [34–36].
From this debate, it is evident that inferences about longer-term
immunobiological kinetics that are derived from short-term
experimental research should be tentative. Our primary concern
in this paper was to illuminate unique immunobiological
characteristics that may result from differences in an individual’s
exposure history. Using two simple within-host models has allowed
us to qualitatively explore some elementary questions about anti-
chlamydial immunity under repeated exposure.
Overall, our results suggest several generalised interpretations
that agree well with previously observed experimental studies: one,
CD4+ T cell responses impart a marked level of immunity to
primary and secondary infections; two, proportional antibody and
CD4+ cell responses contribute in an important way to resolution
of primary infection as well as an individual’s immunity against
reinfection; and three, when reinfection does occur after being re-
exposed in relatively rapid succession (relative to the immunolog-
ical decay time) the resulting infection is less severe and produces a
decreased bacterial load. This latter result has provided significant
insight into the timing of reinfection and the severity and duration
of disease: as long as some level of pre-existing immunity remains,
repeat infections are likely to be of decreased severity and duration
when compared to initial infection. However, this does not appear
to apply to repeat infections that occur at time points after
immunity has waned further.
As mentioned previously, the major immune mechanisms for
controlling Ct infection occurs through depletion of cellular TRP
by IFN-g-inducible IDO [2,11–12]. An effective immune response
will contain a balance of cell-mediated and humoral immune
responses [12]. A failed or weak TH1 response will allow for the
development of antibody- or TH2-mediated hypersensitivity,
whereas an over-stimulated TH1 response will lead to an increased
risk of IFN-g-mediated tissue damage [12].
Our experiments of repeated exposure have highlighted two
novel immunobiological outcomes that appear to connect the
formation of antibody to the outcome infection and long-term
protective immunity. Firstly, the in-host models used here suggest
that for frequent exposure to chlamydia, the formation of a
proportional antibody response (i.e., TH1 ! TH2) is not only
central for preventing reinfection, but for regulating an individ-
ual’s CD4+ T cell populations as well. Specifically, antibody will
reduce the population of free EBs, which reduces the levels of
infected cells; a lower magnitude of infected cells will regulate the
activation and proliferation of CD4+ T cells, the production of
IFN-g, and potentially lessen the risk of inflammatory damage.
However, a lack of a proportional antibody response during
frequent repeated infection allows for more infected cells to be
produced, thus requiring higher levels of CD4+ T cells to
eliminate infection.
Although TH1 CD4+ responses are positively correlated with
the production of IFN-g, and an increased risk of inflammatory
damage [14], our results indicate that the likelihood of persistent
infection also increases. Because fluctuations between acute
replication, IFN-g-mediated immune responses, and persistent
infection are believed to the norm with chlamydia infections [12],
our results outline a potentially previously unidentified mechanism
of chronic infection that is driven by continual disproportionately
high TH1 responses. To our knowledge, research into the link
between persistent infection and immune responses has not
assigned an important role to the prolonged activity to IFN-g-
mediated mechanisms.
The second outcome demonstrates that the formation of
chronic infection, in the presence of disproportionately high levels
of TH1 CD4+ responses, also paradoxically appears to be
associated with the development of complete immunity. Previous
observational research using highly sexually active human
populations (i.e., commercial sex workers) has reported that
despite high prevalence rates of STIs [37,38], some degree of
protective long-term immunity may exist [18–19]. At a general
level, the results from both our simple and extended models
appear to support these previous observations: frequent re-
exposure can yield stable and persistent elevated immune memory
(Figures 4 and 5). It also appears that individuals experiencing
brief periods of more-frequent rates of exposure (Figure 6)
experience immunity that does not prevent infection, but will
likely reduce the duration and severity of secondary infection and
disease.
Although the accumulation of immunity through repeated
infection has been assumed elsewhere [20], our results demon-
Figure 4. Multiple re-exposure experiments using the basic
model. Displayed are the kinetics of infected cells (A), and CD4+ T cells
(B) for single reinfection at either 100, 200, 300, or 600 days after initial
infection in the basic model. Also included is the simulated kinetics of
frequent re-exposure every 30 days over a span of 300 days after initial
infection. As time of second infection occurs at increasingly long
intervals from initial infection, the magnitude of infection and immune
responses increases. For frequent re-exposure, it should be noted that
oscillatory behavior continued after the removal of further infection.
Single and multiple re-exposure scenarios are used to represent
individuals that have low and high sexual exposure to chlamydia,
respectively. Black arrow indicates point of initial infection (common to
all scenarios). The magnitude and time evolution of the system of
equations in both (A) and (B) are presented non-dimensionally.
doi:10.1371/journal.pone.0006886.g004
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exposure, removal of repeated exposure allows levels of immune
cells to return to near baseline levels (Figure 6). Taken together,
our results suggest that the natural development of complete, long-
lived immunity to chlamydia may be the exception rather than the
rule. This leads us to conclude that – for all but the most heavily
exposed – both partial and complete immunity, in the long-term,
may simply be an artifact of continued exposure coupled with
disproportionate immune responses. At the very least, it appears
that the formation of immune memory to chlamydia infection,
among those frequently exposed, may not fit the standard precepts
of infection and acquired immunity. This appears to challenge
current evidence of chlamydial immunity and suggests the need for
novel empirical data.
Because the models here are stylized descriptions of chlamydia
infection and host immune responses, we have erred on the side of
starting simple to help gain some initial insights into model
dynamics. In particular, we chose to develop these within host
models under simple assumptions about the spread of infection in
the genital tract and the development of immune memory. For the
spread of infection, we chose to develop a within-host model that
describes populations of cells within the genital tract that interact
in a mass-action like (or random mixing) process. While this is
often assumed for most mathematical models of infectious disease
spread, it could be argued that this is not a realistic assumption for
the genital tract (i.e., it is not a homogenously-mixed system), and
that our model does not capture events that occur within the
genital tract. There are indeed better representations of an
infection in the genital tract than those of mass-action. For
example, we might have considered density-dependent, saturation-
based, or spatial components as a model for infection spread. For
the development of immune memory, we chose a heuristic
approach over a mechanistic description. Because memory cells
are activated at a faster rate than naive cells, and because they may
proliferate before they acquire effector functions, the inclusion of
state variable for immune memory would have altered the time
course of our re-challenge experiments changed the dynamics of
the results we have presented. As a result, the repeat exposures
may have to be separated by a longer period of time to see the
effects that were observed here.
Models are only as useful as the data available and parameter
values estimated to inform them. It is important to recognize that,
while our models were able to adequately reproduce the qualitative
behaviour from laboratory results, they were calibrated without
Figure 5. Multiple re-exposure experiments using the extended model. Displayed are the kinetics of infected cells (A), CD4+ T cells (B), and
chlamydia-specific antibody (C) for single reinfection at either 100, 200, 300, or 600 days after initial infection in the extended model. Also included is
the simulated kinetics of frequent re-exposure every 30 days over 300 days after initial infection under antibody deficiency. As time of second
infection occurs at increasingly long intervals from initial infection, the magnitude of infection and immune responses increases. It should be noted
that, for frequent re-exposure scenarios oscillatory behavior occurred once a deficiency in antibody is created, and they continue once infection
pressure is removed. This demonstrates the dominance of a critical negative feedback antibody levels have on controlling reinfection. Black arrow
indicates point of initial infection (common to all scenarios). For parts (B) and (C), initial immune cell levels are higher (part B) and lower (part C) at
initial infection because of imposed antibody deficiency. The magnitude and time evolution of the system of equations in both (A), (B), and (C) are
presented non-dimensionally.
doi:10.1371/journal.pone.0006886.g005
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cells that have been published in previous experimental and
mathematical studies [e.g., Refs 39–42]. While we have no doubt
that these previously published papers are a valuable source of
information, many focused their attention on primate models, or
have been calibrated to very specific laboratory data that may not
directly translate to the models we have used here. We are currently
evaluating how the results of these papers may be applied to better
inform our models. What is important to note is whether these
models are able to shed light on specific questions in a way that
alternative models, including human intuition, does not.
Despite the limitations discussed, with some modification these
within-host models might be able to lend valuable insight towards
two prominent, and less well-understood, characteristics of
chlamydia infections [2]. The first is distinguishing immunobio-
logical characteristics of symptomatic infection and asymptomatic
infection; the second is estimating the likelihood of immunopatho-
genesis given either a persistent infection, or a number of previous
chlamydial exposures. Collaborative efforts between ongoing
modelling work and the collection of quantitative immunological
information will be of great help determining important
immunobiological thresholds for very specific clinical phenomena.
In general, control of STIs has been a remarkable yet
incomplete public health achievement [19]. While a large amount
of heterogeneity in the transmission of chlamydia has been
attributed to variability human behaviour, immunobiological
heterogeneity is also thought to influence its transmission [19]. A
direct assessment of how immunobiology influences the transmis-
sion of chlamydia will require the use of theoretical tools that unify
the features of immunology and sociology into an integrated
ecological template [43–44]. Ideally, this will highlight any
interdependence of chlamydia control programs and within-host
immunobiology have on current epidemiological trends [45].
Supporting Information
Supporting Information S1 This is the most recent version of
the supporting information.
Found at: doi:10.1371/journal.pone.0006886.s001 (0.05 MB
DOC)
Figure S1 State space trajectory diagrams of CD4+ T cells
versus Free Elementary Bodies for the basic and extended models
during frequent re-exposure. For the basic model (A), re-exposure
results in damped oscillations to an endemic equilibrium and high
CD4+ T cell concentrations. However, in the extended model (B)
re-exposure will produce a trajectory that approaches a stable limit
cycle.
Found at: doi:10.1371/journal.pone.0006886.s002 (0.50 MB
TIFF)
Figure 6. Higher initial re-exposure followed by a long period of no exposure. Displayed is the kinetics of infected cells (A), CD4+ T cells (B),
and chlamydia-specific antibody (C) for the extended model with re-exposure every 100 days over a span of 300 days followed by single re-exposure
900 days after initial infection. With some level of pre-existing ‘immunity’ reinfection is demonstrated to be less severe. However, once infection
pressure is removed, and immunity is allowed to wane, reinfection closely resembles initial infection. These scenarios were used to represent higher
initial rates of exposure, between 100 and 300 days, followed by low exposure between 300 and 900 days. Black arrow indicates point of initial
infection. The magnitude and time evolution of the system of equations in both (A), (B), and (C) are presented non-dimensionally.
doi:10.1371/journal.pone.0006886.g006
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